Employer-Paid

Lawmakers should take "bold steps" to strengthen employer plans, reduce costs, promote telehealth and combat the mental health crisis, wrote the American Benefits Council in a letter.

Just days after the other two drugmakers dropped their prices, Sanofi is capping the cost of its most prescribed insulin at $35 for the privately insured, as a price gouging lawsuit against all three drugmakers gets underway.

The leaders from various sectors of the health care industry sent a letter to the Centers for Medicare & Medicaid Services in support of the proposed Medicare Advantage payment policy changes for 2024.

Finding top talent is a challenge – with the cost of hiring being one of those challenges, however, hiring remotely can be more cost-effective because there's a wider pool of talent from more affordable states, says a new study.

The battle over access to a key drug used for medication abortions heats up in a Texas courtroom, as Senators send a letter to Walgreens over its recent announcement that it will not dispense abortion pills in 20 states.

The pharmacy chain "deleted internal notes about suspicious prescribers" and allowed "millions of opioid pills" to flow illegally out of stores, alleges the Department of Justice.